“We Are at War”: Mother’s Raw Cry After Son Devin Diagnosed With DIPG Shakes Community to Its Core
Some moments don’t unfold slowly. They detonate.
One second, you’re standing in the middle of an ordinary day. The next, the word “cancer” rips through the room — and nothing in your world will ever look the same again.
For Robin Lisa, that moment is frozen in time. Two brothers standing in stunned silence. A mother watching her child step into a battle he never chose. A diagnosis that no parent is ever prepared to hear: DIPG.
Diffuse Intrinsic Pontine Glioma.
Three letters that carry the weight of devastation.
“We are at war with this disease,” Robin says — and she does not soften her words. There is no polished statement. No carefully curated grief. Just truth. Raw. Unfiltered. Furious.
DIPG is a rare and aggressive brain tumor that primarily affects children. It grows in the brainstem — the area responsible for essential life functions like breathing, heart rate, and movement. Surgery is not an option. Treatment options remain heartbreakingly limited. In 2026, despite advances in so many areas of medicine, this diagnosis still feels like a door slamming shut.
Devin is now one of those children.
But before the hospital rooms, before the medical terminology, before the word “fighter” was attached to his name — he was just a boy. A brother. A son. A child who should have been worrying about homework, games, and scraped knees. Not radiation schedules. Not prognosis statistics. Not survival rates.
The moment the diagnosis was spoken, childhood cracked in real time.
His brothers were there. Old enough to understand that something terrible had just entered their lives. Young enough to still believe the world is supposed to make sense. They stood in shock — processing a reality that no sibling should have to process.
Robin remembers their faces. The confusion. The fear. The silence.
“Two brothers will never forget that moment,” she says. And neither will she.
There is something uniquely cruel about pediatric cancer. It forces language onto children that belongs in war zones. Brave. Strong. Hero. Fighter. Words meant to inspire — but also words that hint at the scale of the battle ahead.
Devin has fought with courage. He shows up for treatments. He endures the nausea, the fatigue, the uncertainty. He listens to doctors describe things no child should need to understand. He smiles when he can. He hopes because the adults around him hope.
But his mother is clear: he shouldn’t have to fight at all.
“This isn’t poetic grief,” she says. “It’s anger.”
Anger that in 2026, families still hear the same devastating statistics. Anger that research funding for rare pediatric cancers lags behind. Anger that medicine can perform miracles in some areas — yet remains nearly powerless against DIPG.
It’s the kind of anger that doesn’t fade quietly. It lingers in hospital hallways. It follows you home. It sits beside you in the dark when the house is finally still.
Every scan brings dread. Every appointment carries a silent prayer. Every small symptom triggers a wave of fear that is impossible to fully explain to someone who hasn’t lived it.
Robin speaks openly about that fear — not because she wants sympathy, but because silence feels heavier.
“There are moments I want to scream,” she admits.
Scream at the unfairness. Scream at the randomness. Scream at a system that still hasn’t found answers fast enough for children like her son.
Yet amid the fury, there is fierce love.
The kind that holds a child’s hand through procedures. The kind that memorizes medication schedules. The kind that whispers hope even when statistics try to steal it.
The community around them has begun to rally — sending messages, offering meals, sharing Devin’s name. Because sometimes, when science feels limited, presence is what people can give.
And Robin wants one thing above all else: that her son’s name not fade into anonymity.
“Please keep Devin in your prayers,” she says.
Not as a headline. Not as a tragic story. But as a child. A real boy with a laugh, with favorite things, with brothers who look up to him.
Pediatric cancer often becomes a symbol in conversations about resilience. But behind every awareness campaign is a family navigating daily heartbreak. Balancing hope with realism. Strength with exhaustion.
DIPG does not just affect the child diagnosed. It ripples outward — into siblings’ lives, into marriages, into friendships. It rearranges priorities. It redraws futures. It forces families to measure time differently.
For Devin’s brothers, life is now divided into before and after. Before the diagnosis. After the diagnosis. Before innocence cracked. After it shattered.
And still, they stand beside him.
In 2026, a mother is asking a question that echoes across countless pediatric oncology wards: Why are we still here? Why are children still facing diseases we cannot stop?
It is not a rhetorical question. It is a plea. For research. For urgency. For attention. For change.
Until that change comes, families like Robin’s continue to wake up every day and walk into battle — not because they want to, but because they must.
Some moments explode. And life is never the same again.
For this family, that moment has a name: DIPG.
And that name now sits beside another name — Devin.
Remember it.
Leave a Reply